https://lamintang.org/journal/index.php/ijcims/issue/feedInternational Journal of Clinical Inventions and Medical Sciences (IJCIMS)2025-05-14T04:56:56+00:00Yusram, S.Pd., M.Pd.journal.lamintang@gmail.comOpen Journal Systems<p>International Journal of Clinical Inventions and Medical Sciences (IJCIMS) provide a valuable platform for academicians, scholars, researchers and students to share their knowledge, ideas, development and insights of the most up-to-date research that focuses on the area of Medical/Biomedical Research, Preclinical Research and Clinical Research.</p> <p>IJCIMS published in English and twice a year (March and September).</p>https://lamintang.org/journal/index.php/ijcims/article/view/764Comprehensive Analysis to Address the Spread of Tuberculosis2025-03-25T09:29:28+00:00Theint Myo Aungtheint.aung@gmail.comMin Htun San_@gmail.comWin Latt Khan_@gmail.comMyint Sein Thet_@gmail.com<p>This research explores the elevated incidence of tuberculosis (TB) in Myanmar, where the burden of the disease dramatically surpasses the worldwide average of 500 cases per 100,000 individuals. The research seeks to investigate elements leading to TB prevalence, recognize obstacles to control measures, and suggest practical recommendations. A mixed methods strategy was employed, integrating quantitative information from health statistics in Yangon, Mandalay, and the rural regions of Chin and Shan States with qualitative information gathered from interviews with healthcare professionals and impacted communities. The study results indicate that poverty, malnutrition, limited access to health services, and a lack of awareness are major factors contributing to elevated TB rates, exacerbated by the rise of multidrug-resistant TB (MDR-TB). Insufficient health care systems and cultural prejudices also hinder successful TB management. The research emphasizes the necessity for focused interventions, such as enhancing access to healthcare services, boosting public awareness, and establishing thorough TB screening initiatives. The research highlights the importance of tackling the underlying causes of poverty and malnutrition to lower TB vulnerability. These results have important consequences for expanding TB control initiatives, not just in Myanmar but also in other nations encountering comparable socio-economic issues. Future studies ought to concentrate on assessing the efficacy of the suggested interventions and investigating creative approaches to enhance access to TB treatment while decreasing stigma.</p>2025-03-25T00:00:00+00:00Copyright (c) 2025 International Journal of Clinical Inventions and Medical Sciences (IJCIMS)https://lamintang.org/journal/index.php/ijcims/article/view/772Strengthening Global Health Through One Health2025-03-25T09:29:25+00:00Anna Svenssonsvensson95.anna@gmail.comMarie Winder_@gmail.comCleveland Monika Bjorkmanbjorkman_monika@yahoo.comMinguez öderholm_@gmail.com<p>This study examines the implementation of the One Health paradigm in Sweden, which integrates human, animal, and environmental health sectors to address global health challenges. The primary research objective is to explore how Sweden has applied the One Health approach to manage zoonotic diseases, antimicrobial resistance (AMR), and the health impacts of climate change. Using a descriptive case study methodology, data were collected through documentary analysis and semi-structured interviews with 17 respondents from key institutions such as Karolinska Institutet, the Swedish University of Agricultural Sciences (SLU), and the Swedish National Veterinary Institute. The findings reveal that Sweden has made significant strides in cross-sectoral collaboration, enhanced surveillance systems, and improved policy responses, particularly in managing zoonotic diseases and controlling AMR. Sweden’s framework for data sharing and coordination between sectors serves as a model for other nations facing similar health challenges. The study identifies Sweden's approach to addressing climate change as part of the One Health framework as a critical contribution to global health. Future research should focus on overcoming barriers to local-level collaboration, improving data-sharing mechanisms, and developing real-time coordination strategies to further strengthen the One Health approach globally.</p>2025-03-25T00:00:00+00:00Copyright (c) 2025 International Journal of Clinical Inventions and Medical Sciences (IJCIMS)https://lamintang.org/journal/index.php/ijcims/article/view/805Opportunities and Challenges in the Development of Genomic Technologies2025-03-25T09:29:15+00:00Gure Çehreli Kozargure.kozar@gmail.comYilmaz Murat_@gmail.comMeltem Nurcan Tunç_@gmail.com<p>Genomic technologies have made rapid progress in modern medicine, providing a deeper understanding of the genetic factors that influence health and disease. In Turkey, these technologies have significant potential to transform medical diagnostics, address genetic disorders, and contribute to personalized therapies. This study explores the development, impact, and challenges of genomic technologies in the Turkish healthcare system through a descriptive case study approach. Document analysis and semi-structured interviews with 20 experts, including researchers, healthcare practitioners, and policymakers, were conducted. The findings indicate Turkey’s growing commitment to genomic research, with increased funding allocations and modern facilities. Genomic technologies have significantly improved diagnostic accuracy for genetic disorders and cancer, particularly through Next-Generation Sequencing (NGS) and genomic profiling. However, challenges such as limited funding (only 10% of the healthcare budget), shortage of skilled personnel, and regulatory gaps persist. Despite these barriers, Turkey shows strong potential to become a leader in genomic research. Recommendations for future research include addressing these challenges through increased investment, public awareness campaigns, and workforce development. By overcoming these obstacles, Türkiye can successfully integrate genomic technologies into its healthcare system, improving medical care and promoting personalized treatment</p>2025-03-25T09:14:59+00:00Copyright (c) 2025 International Journal of Clinical Inventions and Medical Sciences (IJCIMS)https://lamintang.org/journal/index.php/ijcims/article/view/808Evaluation of Pharmaceutical Services at Pharmacy X Based on the Regulation of the Minister of Health Number 73 of 20162025-05-14T04:56:56+00:00Hansel Hens Tangkashanseltangkas@gmail.comNormaidah Normaidahnormaidah@ulm.ac.idMulia Muliamuliaqlia@gmail.comRaudatul Jannah Asajannahasa23@gmail.comVina Melindawativinamelindawati11@gmail.com<p>Pharmaceutical services are crucial in enhancing individuals' quality of life. Pharmacies must adhere to and apply the standard pharmaceutical services outlined in the Minister of Health Regulation Number 73 of 2016. Standard Pharmaceutical services still cannot be implemented perfectly in society, which impacts people's quality of life. This research provides relevant information for policy-making in the health sector and encourages the improvement of the quality of pharmaceutical services in the future. Pharmacy X has been established for 13 years and is in the middle of the market. Pharmacy X is also close to the Kapuas River. Both factors make Pharmacy X easily accessible to the community. This study aims to evaluate pharmaceutical services at Pharmacy X, Kapuas City. The method used in this research was qualitative, with direct observation and interview. This method was used to obtain results regarding the evaluation of pharmaceutical services. The results showed that Pharmacy X had already implemented standard pharmaceutical services. Nonetheless, it would be better if Pharmacy X had a counseling room that was large enough. Pharmacy X has played a role in enhancing the safety and efficacy of drug therapy for patients. In the future, enhancing technology-driven services and improving community access may serve as a priority to elevate the standard of pharmaceutical services. The professional practice of pharmacists in Indonesia is necessary to protect patients from inappropriate services. If pharmaceutical service standards are not implemented properly, there is a risk of endangering patient safety and increasing inequalities in access to health services.</p>2025-03-25T09:12:23+00:00Copyright (c) 2025 International Journal of Clinical Inventions and Medical Sciences (IJCIMS)https://lamintang.org/journal/index.php/ijcims/article/view/823Dietary Intervention with Chayote for Blood Pressure Control2025-03-25T09:29:18+00:00Andi Almeira Zocha Ismailalmeira_zocha@gmail.comAndi Regina Acacia Ismail_@gmail.comAliyyah Yusram_@gmail.comSitti Jamilah_@gmail.com<p>High blood pressure is a major risk factor for heart-related conditions, such as stroke and heart attack. Dietary management is essential for regulating blood pressure, and foods high in potassium, like chayote (<em>Sechium edule</em>, Latin) (<em>labu siam</em>, Indonesian), are becoming recognized for their possible antihypertensive benefits. This research examines the effects of eating chayote on the control of blood pressure in people with hypertension. An experimental approach was employed, involving three participants with hypertension and a history of stroke. The participants ate chayote combined with oats as a substitute for rice every day for a week. Blood pressure readings were taken prior to and following the intervention to evaluate alterations in systolic and diastolic values. The results indicate a notable decrease in blood pressure. Typically, systolic pressure dropped by 15 mmHg (9.4%), whereas diastolic pressure fell by 10 mmHg (10.5%). These findings indicate that chayote aids in blood pressure control due to its elevated potassium levels, promoting sodium elimination and supporting electrolyte equilibrium. Moreover, its fiber and flavonoids promote heart health by lowering cholesterol levels and minimizing oxidative stress. Although the outcomes are favorable, this research is constrained by its limited sample size and brief duration. Future studies should include larger and more varied populations, longer intervention durations, and an examination of chayote’s bioactive compounds to gain a clearer understanding of its long-term impact on blood pressure control.</p>2025-03-25T09:13:45+00:00Copyright (c) 2025 International Journal of Clinical Inventions and Medical Sciences (IJCIMS)